Regulatory Spine Medtronic Announces FDA approval of Infuse™ bone graft for one-and-two level Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures byJosh SandbergFebruary 17, 2026
Regulatory Spine icotec receives FDA approval for the CMORE® CT system, extending its BlackArmor® carbon/PEEK composite technology to the posterior cervicothoracic spine byJosh SandbergNovember 13, 2025
Regulatory OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family byTim AllenOctober 28, 2025
Regulatory Spine Top Stories Centinel Spine® Receives Two-Level FDA Approval for prodisc® C Vivo and prodisc® C SK Match-the-Disc™ Cervical Total Disc Replacement Devices byTim AllenOctober 14, 2025
Regulatory U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor byNoah SimmonsSeptember 29, 2025
Regulatory Spine Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion byJosh SandbergJune 23, 2025
Recon Regulatory Sports Medicine Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant byTim AllenMay 20, 2025
Recon Regulatory BioPoly® Knee FDA-Approved Clinical Study is Now Published on ClinicalTrials.gov byTim AllenApril 23, 2025
Biologics Spine Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use byJosh SandbergSeptember 24, 2024
Regulatory Spine DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease byTim AllenJuly 16, 2024
